drugset / Trial / NCT03167905

CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)

NCT03167905

Phase 2/3 Active not recruiting 881 enrolled KK Women's and Children's Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Postnatal depression affects about 10-15% of women after childbirth. Approximately 3-5% of women experience a moderate-to-severe depression that requires medical attention. This study aims to investigate the implication of pain relief choice in reducing the postnatal depression of women who deliver their babies.

Timeline

Start
2017-06-15
Primary completion
2021-07-19
Completion
2026-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Entonox Unknown
Subject Fentanyl Other / unclassified 2 ug/ml Other
Comparator Meperidine Unknown 75 mg Intramuscular
Comparator Remifentanil Small molecule 20 ug/ml Intravenous
Comparator Remifentanil Small molecule 40 ug/ml Intravenous
Subject Ropivacaine Other / unclassified 0.1 % Other

Indications